Celularity (CELUW) Current Taxes (2019 - 2020)
Celularity (CELUW) reported Current Taxes of $81701.0 for Q3 2020, down 21.66% quarter-over-quarter from $104284.0 in Q2 2020.
Celularity (CELUW) Current Taxes (2019 - 2020) Analysis & Trends
Celularity (CELUW) has 2 years of Current Taxes data on file, last reported at $81701.0 in Q3 2020.
- Current Taxes for Q3 2020 came in at $81701.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $81701.0 (changed N/A YoY), and the FY2019 annual result was $18883.0, changed N/A from the prior year.
- Current Taxes retreated to $81701.0 in Q3 2020 per CELUW's latest filing, from $104284.0 in the prior quarter.
- Over five years, Current Taxes peaked at $116891.0 in Q2 2019 and troughed at $18883.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 81,701.00 |
| Jun 30, 2020 | 104,284.00 |
| Mar 31, 2020 | 62,092.00 |
| Dec 31, 2019 | 18,883.00 |
| Jun 30, 2019 | 116,891.00 |